Dynavax (DVAX) Receives FDA Complete Response Letter for HEPLISAV-B BLA in HBV
Go back to Dynavax (DVAX) Receives FDA Complete Response Letter for HEPLISAV-B BLA in HBV| Dynavax Technologies Corporation (NASDAQ: DVAX) | Delayed: 11.28 -0.14 (1.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.42 | 52 Week High | $29.86 | |||
| Open | $11.41 | 52 Week Low | $3.20 | |||
| Day High | $11.41 | P/E | N/A | |||
| Day Low | $11.17 | EPS | $-0.41 | |||
| Volume | 808,095 | |||||
